Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands.
about
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trialHow the interval between prime and boost injection affects the immune response in a computational model of the immune system.Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2-10-year-old children: results of an open, randomised, controlled study.Routinely vaccinating adolescents against meningococcus: targeting transmission & diseaseMeningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the NetherlandsThe impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?Impact of vaccination on meningococcal epidemiologyNeed for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands.The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012.The endgame for serogroup a meningococcal disease in Africa?Modelled evaluation of multi-component meningococcal vaccine (Bexsero®) for the prevention of invasive meningococcal disease in infants and adolescents in the UK.
P2860
Q28650557-EBB672A3-058B-44E7-868F-F645F403FAD9Q36246834-3805BDFB-484F-401B-8669-6A7D66679EEDQ36781534-4DC874E6-8F16-4709-A658-F14A0BA37A4AQ36825737-A5C22B0B-5956-40E2-9347-70FFEB1007A0Q36891586-A04DCF13-7AE9-4279-924A-172F6A1CC9E4Q37037419-6824A897-042D-4B3E-806A-38D2B729EE25Q37130791-72E39E74-FB05-445F-B253-7D818AC8EA64Q38931495-5E668564-A8F7-43B3-B494-0AA85BB8650EQ42204205-4EBBD20E-78A8-426C-8042-75B5A56968CAQ42577186-1351B585-2A4F-439A-8B40-B27B62A7FE9EQ44735039-6A4B0F8A-4025-4EAA-ACB6-DE8B67F2B760
P2860
Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Is a single dose of meningococ ...... perience from the Netherlands.
@ast
Is a single dose of meningococ ...... perience from the Netherlands.
@en
Is a single dose of meningococ ...... perience from the Netherlands.
@nl
type
label
Is a single dose of meningococ ...... perience from the Netherlands.
@ast
Is a single dose of meningococ ...... perience from the Netherlands.
@en
Is a single dose of meningococ ...... perience from the Netherlands.
@nl
prefLabel
Is a single dose of meningococ ...... perience from the Netherlands.
@ast
Is a single dose of meningococ ...... perience from the Netherlands.
@en
Is a single dose of meningococ ...... perience from the Netherlands.
@nl
P2093
P2860
P356
P1476
Is a single dose of meningococ ...... perience from the Netherlands.
@en
P2093
Arie van der Ende
Germie P J M van den Dobbelsteen
Guy Berbers
Nynke Y Rots
Patricia Kaaijk
P2860
P2888
P356
10.1186/1471-2334-12-35
P577
2012-02-08T00:00:00Z
P5875
P6179
1044117756